HEREDITARY MACULAR DYSTROPHIES. PART 1. DYSTROPHIES ASSOCIATED WITH DYSFUNCTION OF RETINAL PIGMENT EPITHELIAL CELLS

Abstract

Purpose - to acquaint the reader with a relatively rare heterogeneous group of diseases - hereditary macular dystrophies associated with damage to cells of retinal pigment epithelium and external segments of photoreceptors. А review of the literature based on publications from the Medline scientific medical articles database is presented. The review includes a description of the clinical picture, consideration of diagnosis and differential diagnosis of the main juvenile macular dystrophies, illustrated by own clinical examples.

Keywords

macular dystrophy / Stargardt’s dystrophy / Best’s dystrophy / retinal pigment epithelium / lipofuscin / review

References

[1] Stargardt K. Uber familiare, progressive degenerationin der makulagegend des auges. Graefes Arch. Clin. Exp. Ophthalmol. 1909; 71: 534-50.

[2] Шамшинова А.М. Наследственные и врожденные заболевания сетчатки и зрительного нерва. М.: Медицина, 2001.

[3] Allikmets R., Singh N., Sun H., Shroyer N.F., Hutchinson A. et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat. Genet. 1997; 15: 236-46.

[4] Шамшинова А.М., Зольникова И.В. Молекулярно-генетические основы патогенеза наследственных дистрофий сетчатки. Медицинская генетика. 2004; 4: 160-9.

[5] Zolnikova I.V., Rogatina E.V., Egorova I.V., Levina D.V., Demenkova O.N., Strelnikov V.V., Tanas A.S., Skvortsova N.A., Barh D., Prikaziuk E.G., Ivanova M.E. Stargardt disease-associated mutation spectrum of a Russian federation cohort. European Journal of Medical Genetics. 2017; 60(2): 140-7.

[6] Зольникова И.В., Рогатина Е.В. Дистрофия Штаргардта: клиника, диагностика, патогенез, лечение. Клиницист. 2010; 1: 29-33.

[7] Franceschetti A., Francois J. Fundus flavimaculatus. Arch. d’Ophthalmol. 1965; 25: 505-30.

[8] Delori F.C., Staurenghi G., Arend O., Dorey K., Goger D.G., Weiter J.J. In vivo measurements of lipofuscin in Stargardt’s disease - fundus flavimaculatus. Invest. Ophthalmol. Vis. Sci. 1995; 36: 2327-31.

[9] Fishman G.A., Farber M., et al. Visual acuity loss in patients with Stargardt’s macular dystrophy. Ophthalmology. 1987; 94: 809-14.

[10] Зольникова И.В., Карлова И.З., Рогатина Е.В. Макулярная и мультифокальная электроретинография в диагностике дистрофии Штаргардта. Вест. офтальмол. 2009; 1(125): 41-6.

[11] Berson E.L. Retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 1993; 34(5): 1659-76.

[12] Greenstein V.C., Nunez J., Lee W., Schuerch K. et al. A comparison of en face optical coherence tomography and fundus autofluorescence in Stargardt disease. Invest. Ophthalmol. Vis. Sci. 2017; 58 (12): 5227-36.

[13] Best F. Ueber eine hereditare maculaaffektion. Z. Augenheklkd. 1905; 13: 199-212.

[14] Marmorstein A.D., Kinnick T.R., Stanton J.B., Johnson A.A, Lynch R.M., Marmorstein L.Y. Bestrophin-1 influences transepithelial electrical properties and Ca2+ signaling in human retinal pigment epithelium. Molecular Vision. 2015; 21: 347-59.

[15] Зольникова И.В., Рогатина Е.В., Орловская Л.С., Пономарева Е.Н. Мультифокальная, макулярная и паттерн-ЭРГ при вителлиформной макулодистофии Беста. Офтальмология. 2006; 3(2): 29-36.

[16] Katargina L., Denisova E., Kogoleva L., Novikova O., Osipova N. Choroidal neovascularization secondary to best viteliform macular dystrophy: is it rare? Eur. J. Ophthalmol. 2017; 27 (5): Abstracts from the 43 EPOS Annual Meeting, 31 August-2 September 2017. - Oxford, UK. - P. e157.

RIGHTS & PERMISSIONS

Eco-Vector